Assoc Prof Jamus Jerome Lim asked the Minister for Health (a) what are the considerations that the Ministry takes into account when deciding the treatments to be included in the Cancer Drug List; and (b) what factors typically lead to the inclusion or removal of a particular drug from the List.
Mr Ong Ye Kung: The key factors that the Agency for Care Effectiveness considers are that treatments should be both clinically-effective and cost-effective, in order to be included in the Cancer Drug List (CDL).
For treatments that are already assessed and on CDL, they will remain on the list unless there are specific reasons to remove them, such as if the company defaults on contractual agreements with the Ministry of Health or upon company request or safety recalls.
Ministry of Health
9 January 2024
https://sprs.parl.gov.sg/search/#/sprs3topic?reportid=written-answer-15258
Office of the Leader of the Opposition 